Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacologic provocation and dexamethasone suppression test sensitivity.

C M Swartz1, K Breen, V S Wahby

  • 1Department of Psychiatry, Chicago Medical School, North Chicago, Ill.

Neuropsychobiology
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Climate Change-Related Risks of Gender-Based Violence (GBV) Among 2SLGBTQIA+ University Students and Emergent Adults: A Scoping Review.

Journal of homosexuality·2025
Same author

Immunotherapy- A double Edged Sword; A case of Fatal Myocarditis and Complete Response

Irish medical journal·2019
Same author

Tuberculous abscess causing disruption of the cranium.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2010
Same author

Human intravenous immunoglobulin and its traceability.

Irish medical journal·2009
Same author

A multicentre longitudinal observational study of changes in self reported health status in people with Parkinson's disease left untreated at diagnosis.

Journal of neurology, neurosurgery, and psychiatry·2006
Same author

Charcoal enhancement of treatment for tricyclic-induced mania.

Pharmacopsychiatry·2002
Same journal

Kynurenic Acid Offers Added Value in Predicting ECT Outcomes in Depression.

Neuropsychobiology·2026
Same journal

Decreased Specific Pavlovian-to-Instrumental Transfer Effect in Internet Gaming Disorder Following Short-Term Abstinence from Gaming.

Neuropsychobiology·2026
Same journal

Clinicians' Preferences and Attitudes Toward the Use of Lithium in the Treatment of Bipolar Disorders in Mexico.

Neuropsychobiology·2026
Same journal

Prevalence of psychotic symptoms and their clinical correlates in elderly major depressive disorder patients with subclinical hypothyroidism.

Neuropsychobiology·2026
Same journal

The Long- Term Course of Adolescent-Onset Major Depressive Disorder in Females: A 10-Year Cohort Study on Recurrence, Suicide Risk, and Service Use.

Neuropsychobiology·2026
Same journal

Evidence on Deliberate Self-Harm, Suicidal Ideation and Suicides in Pakistan: A Scoping Review of Methods, Contributing Factors and Associated Mental Disorders.

Neuropsychobiology·2026
See all related articles

The dexamethasone suppression test (DST) showed low sensitivity for depression diagnosis, even with modifications. Enhancing the DST with theophylline or lorazepam discontinuation did not significantly improve its diagnostic accuracy for melancholia.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Background:

  • The dexamethasone suppression test (DST) is a diagnostic tool for depression.
  • Improving the sensitivity of the DST is crucial for accurate diagnosis of melancholic depression.

Purpose of the Study:

  • To evaluate the effectiveness of modifying the standard 1-mg dexamethasone suppression test (DST) to improve its sensitivity in diagnosing depression.
  • To assess the impact of theophylline, caffeine, and lorazepam discontinuation on DST sensitivity.

Main Methods:

  • The standard 1-mg DST was administered to 10 depressed inpatients.
  • The DST was repeated with theophylline or caffeine administration.
  • The DST was also performed after 3 days of lorazepam with abrupt discontinuation.

Related Experiment Videos

Main Results:

  • The standard DST showed a sensitivity of 20% (2 out of 10 patients).
  • Modifications increased sensitivity to 40%, with 2 patients changing from suppression to nonsuppression after lorazepam discontinuation, and 1 of those also changing after theophylline.
  • This increase in sensitivity was statistically significant but remained substantially below the desired 80% minimum.

Conclusions:

  • Modifying the DST with theophylline, caffeine, or lorazepam discontinuation did not achieve a consistently high sensitivity for diagnosing depression.
  • The findings suggest that achieving an 80% DST sensitivity in melancholia may be difficult with current modifications.
  • Further research is needed to develop more sensitive diagnostic markers for depression.